Skip to content
Search

Latest Stories

Submit Guest Post

BAPS Abu Dhabi to host webinar series by Swami Brahmaviharidas

BAPS Abu Dhabi to host webinar series by Swami Brahmaviharidas

A LEADING Indian spiritual leader, Pujya Swami Brahmaviharidas, will be the keynote speaker at a webinar series organised by the Bochasanwasi Shri Akshar Purushottam Swaminarayan Sanstha (BAPS) in Abu Dhabi.

Titled “Leading Consciously,” the talk on June 5 has the theme of leadership.


There will be a talk by Pujya Swami Brahmaviharidas followed by a question and answer session.

The UAE’s minister of tolerance and co-existence, HE Sheikh Nahayan Mabarak Al Nahayan, will be the guest of honor at this event.

The webinar on June 5 will begin at 5 pm GST and will last till 6:15 pm GST.

Click here to join the webinar.

IMG 20210524 WA0001

BAPS in Abu Dhabi is building a temple which has envisioned in 1997 by the late HH Param Pujya Pramukh Swami Maharaj. The UAE government announced its decision to provide land for building the temple in 2017 and foundation work began in 2019-2020.

As India battles its second wave of the Covid-19 pandemic, BAPS Abu Dhabi has been proactive in providing relief work. Earlier this month, the organisation dispatched its second Covid-19 relief shipment to India, which included the first two cryogenic tanks filled with liquid oxygen (LOX).

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

cervical -cancer-hpv-vaccine

HPV is the most common sexually transmitted infection

Photo for representation: iStock

HPV vaccine reduces cervical cancer deaths to near zero, study finds

Highlights

  • No women aged 20–24 died from cervical cancer in England between 2020 and 2024
  • HPV vaccination is estimated to have prevented nearly 200 deaths among young women
  • Study provides first direct evidence linking HPV vaccination to reduced cervical cancer mortality
  • Vaccine introduced for girls in 2008 in the UK
  • Researchers say higher vaccination uptake is needed to protect future gains

THE HPV vaccine for cervical cancer has reduced the risk of dying from the disease before the age of 30 in England to almost zero, the first study of its kind showed on Thursday (18).

Keep ReadingShow less